Our main aim in the present investigation, preparation of a drug-drug coamorphous system (CAM) of Apremilast (APR) and Indomethacin (INDO) to improve physiochemical properties, solubility and stability. Various solid-state characterization techniques were used to characterize the prepared APR-INDO CAM system. Single Tg in DSC, hallow pattern in PXRD, and absence of birefringence in PLM indicate the formation of the CAM system between APR and INDO. The molecular level interaction in the CAM system was studied using ATR-FTIR and 1H NMR. The molecular modeling-based analysis was performed to understand intermolecular interactions in the CAM system. Solubility and dissolution studies were carried out to investigate the benefits of the CAM system over its crystalline and amorphous forms of APR and INDO. The CAM system was stable for five months under 40 ± 2 °C and 75 ± 5 % RH. In the permeation study, CAM system had an 8.19-fold higher flux for APR and a 5.83-fold higher flux for INDO compared to crystalline APR and INDO, respectively. The APR-INDO CAM system showed anti-psoriatic and anti-melanogenic activity from the molecular docking results. As a result, we determined that the developed CAM-based supersaturated system has improved physicochemical properties and physical stability.